BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare Oncology: Thyroid Cancer Market Spotlight

March 05, 2020

Thyroid cancer is caused by the abnormal growth of cells in the thyroid gland tissues, forming a tumor. It is the fifth most common malignancy among females. According to the American Cancer Society’s most recent estimates, in 2019 it is projected that there will be 52,070 new cases of thyroid cancer in the US (37,810 cases in women, and 14,260 cases in men). Patients with thyroid cancer may experience few or no symptoms, although known symptoms of the disease include swelling of the glands in the neck, throat or neck pain, hoarseness, difficulty swallowing and breathing, continuous cough (that is not due to a cold), and lumps in the front part of the neck around the Adam’s apple.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Thyroid Cancer
Back to the top Back to the top